A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
EvolveImmune United, Inc
EvolveImmune United, Inc
OncoC4, Inc.
Sotio Biotech Inc.
Sumitomo Pharma America, Inc.
MacroGenics
Novartis
Incyte Corporation
Incyte Corporation
LigaChem Biosciences, Inc.
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Sumitomo Pharma America, Inc.
Shattuck Labs, Inc.
Shanghai Bovax Biotechnology Co., Ltd.
SCG Cell Therapy Pte. Ltd.
Gene Surgery LLC
Shanghai Bovax Biotechnology Co., Ltd.
Corregene Biotechnology Co., Ltd
HRYZ Biotech Co.
HRYZ Biotech Co.
Inovio Pharmaceuticals
Sierra Oncology LLC - a GSK company
Xencor, Inc.
Advaxis, Inc.
Beijing Health Guard Biotechnology, Inc
Beijing Health Guard Biotechnology, Inc
Beijing Health Guard Biotechnology, Inc
Rubius Therapeutics
Xencor, Inc.
Genocea Biosciences, Inc.
Corregene Biotechnology Co., Ltd
Tarveda Therapeutics
Antiva Biosciences
Antiva Biosciences
Merck Sharp & Dohme LLC
Oryx GmbH & Co. KG
Traws Pharma, Inc.
Cardinal Health 414, LLC
Eli Lilly and Company
INSYS Therapeutics Inc
Mannkind Corporation
Light Sciences LLC